Table II.
HRV‐A (n = 101), no. (%) | HRV‐B (n = 21), no. (%) | HRV‐C (n = 80), no. (%) | χ2 | P‐value | |
---|---|---|---|---|---|
Male gender | 62 (61.4) | 14 (66.7) | 56 (70.0) | 1.481 | 0.477 |
Age in months | 5.436 | 0.245 | |||
≤12 | 53 (52.5) | 7 (33.3) | 37 (46.2) | ||
12.1 to ≤36 | 40 (39.6) | 10 (47.6) | 38 (47.5) | ||
>36 | 8 (7.9) | 4 (19.1) | 5 (6.3) | ||
Median age in monthsa | 15.1 | 23.3 | 14.7 | 1.901a | 0.387 |
Average duration of hospitalization in daysb | 8.4 | 7.7 | 6.7 | 0.186b | 0.830 |
Coinfection | 52 (51.5) | 13 (61.9) | 42 (52.5) | 0.769 | 0.681 |
Underlying diseasec | 5 (5.0) | 1 (4.8) | 2 (2.5) | 0.991 | 0.572 |
Symptoms and signs | |||||
Coughc | 98 (97.0) | 19 (90.5) | 78 (97.5) | 2.583c | 0.253 |
Wheezing | 51 (50.5) | 12 (57.1) | 49 (61.3) | 2.118 | 0.347 |
Fever | 26 (25.7) | 5 (23.8) | 24 (30.0) | 0.547 | 0.761 |
Rhonchus | 49 (48.5) | 12 (57.1) | 50 (62.5) | 3.573 | 0.168 |
Crackles | 83 (82.2) | 18 (85.7) | 67 (83.8) | 0.187 | 0.911 |
Gastrointestinal symptoms | 17 (16.8) | 2 (9.5) | 7 (8.8) | 2.834 | 0.242 |
Supplemental oxygen | 14 (13.9) | 6 (28.6) | 11 (13.8) | 3.156 | 0.206 |
Diagnosisc | 11.286c | 0.056 | |||
Bronchitis | 4 (4.0) | 1 (4.8) | 0 (0) | ||
Bronchopneumonia | 18 (17.8) | 8 (38.1) | 18 (22.5) | ||
Pneumonia | 73 (72.3) | 9 (42.9) | 55 (68.7) | ||
Acute asthmatic | |||||
Bronchopneumonia | 6 (5.9) | 3 (14.3) | 7 (8.8) | ||
Seasonal distribute | 31.914 | 0.000 | |||
Spring | 40 (39.6) | 1 (4.8) | 20 (25.0) | ||
Summer | 13 (12.9) | 7 (33.3) | 5 (6.3) | ||
Autumn | 36 (35.6) | 10 (47.6) | 26 (32.5) | ||
Winter | 12 (11.9) | 3 (14.3) | 29 (36.2) |
Kruskal–Wallis H‐test.
ANOVA.
Fisher's exact test, All the other: Chi‐square test; Seasonal distribution: Spring (March–May), Summer (June–August), Autumn (September–November), Winter (December–February).